Comparative survival analysis of immunomodulatory therapy for coronavirus disease 2019 cytokine storm

S Narain, DG Stefanov, AS Chau, AG Weber, G Marder… - Chest, 2021 - Elsevier
Background Cytokine storm is a marker of coronavirus disease 2019 (COVID-19) illness
severity and increased mortality. Immunomodulatory treatments have been repurposed to
improve mortality outcomes. Research Question Do immunomodulatory therapies improve
survival in patients with COVID-19 cytokine storm (CCS)? Study Design and Methods We
conducted a retrospective analysis of electronic health records across the Northwell Health
system. COVID-19 patients hospitalized between March 1, 2020, and April 24, 2020, were …